Global eradication of poliomyelitis and co-emergence of novel poliovirus strains

Epidemiology

Volumn 7, Issue 6, 1996, Pages 653-

  Arya, Subhash C ^a  

^a Centre for Logistical Research and Innovation India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH; HUMAN; LETTER; PATHOGENICITY; POLIOMYELITIS; POLIOMYELITIS VIRUS; VACCINATION; VIRULENCE;

HUMANS; POLIOMYELITIS; POLIOVIRUS; VACCINATION; VIRULENCE; WORLD HEALTH;

EID: 0030276874     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Knolle H. Problems with the campaign for the global eradication of poliomyelitis. Epidemiology 1996;7:209-210.
2. World Health Organization. Global Programme for Vaccines and Immunization. Programme Report 1994. WHO/GPV/95.1. Geneva: World Health Organization, 1995;41.
3. Hoire H, Sato M, Doi Y, Hashizume S. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine. Vaccine 1996;14:35-41.
4. Martin A, Wychowski C, Benichou D, Crainic R, Girard M. Construction of chimaeric type 1/type 2 poliovirus by genetic recombination. Ann Inst Pasteur Virol 1988;139:79-88.
5. Andrus JK, Strebel PM, de Quadros CA, Olive JM. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bull World Health Organ 1995;73:33-40.
6. Arya SC. Immunotechnological products in adverse global environment. Immunotechnology 1995;1:169-173.
7. Ion-Nedelcu N, Dobrescu A, Strebel PM, Sutter RW. Vaccine-associated paralytic poliomyelitis and HIV infection (Letter). Lancet 1994;343:51-52.